Loading organizations...
§ Private Profile · Leiden, Zuid-Holland, The Netherlands
Biotechnology company using stem cell technology for drug discovery.
Ncardia has raised $80.1M across 4 funding rounds.
Ncardia has raised $80.1M in total across 4 funding rounds.
Ncardia has raised $80.1M in total across 4 funding rounds.
Ncardia's investors include Geoffrey Glass, Marc Foidart, InnovationQuarter, Sambrinvest, SFPI-FPIM, SRIW, Vesalius Biocapital, Alain Parthoens, Gerty Holla, Philippe Degive.
Ncardia has raised $80.1M across 4 funding rounds. Most recently, it raised $60.0M Other Equity in November 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 16, 2021 | $60M Venture Round | Geoffrey Glass | — | Announced |
| Nov 17, 2017 | $12.4M Series B | Marc Foidart | Innovationquarter, Sambrinvest, Sfpi Fpim, Sriw, Vesalius Biocapital | Announced |
| Apr 1, 2017 | $2.7M Venture Round | — | Sambrinvest, Sfpi Fpim | Announced |
| Oct 24, 2014 | $5.1M Series A | Alain Parthoens | Gerty Holla, Philippe Degive | Announced |